Virtual Reality Exposure Therapy in Agoraphobic Participants

NCT ID: NCT00734370

Last Updated: 2018-09-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

55 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-10-31

Study Completion Date

2012-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Virtual Reality Exposure Therapy (VRET) is an effective treatment for anxiety disorders, particularly for specific phobias as fear of heights and fear of flying (e.g. Powers \& Emmelkamp, 2008). Recent technological advances (e.g. more realistic avatars) make research into the efficacy of VRET for participants with elevated agoraphobic symptoms desirable. Therefore, the aim of the present research proposal is to investigate the comparative efficacy of:

1. enhanced VRET making use of the latest avatar technology with
2. exposure in vivo in agoraphobic participants
3. wait-list control.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Panic Disorder Agoraphobia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

VRET

Virtual Reality Exposure Therapy for agoraphobic participants

Group Type EXPERIMENTAL

Virtual Reality Exposure Therapy for agoraphobic participants

Intervention Type BEHAVIORAL

This intervention is comprised of 10 sessions of cognitive behavior therapy for panic disorder and agoraphobia with components of

* Psycho-education, breathing training and cognitive restructuring
* Virtual reality Exposure to agoraphobic situations and interoceptive exposure
* Relapse prevention

Exposure in vivo

Standard exposure in vivo for panic disorder

Group Type ACTIVE_COMPARATOR

Standard exposure in vivo for agoraphobic participants

Intervention Type BEHAVIORAL

This intervention is comprised of 10 sessions of cognitive behavior therapy for panic disorder and agoraphobia with components of

* Psycho-education, breathing training and cognitive restructuring
* Standard exposure in vivo to agoraphobic situations and interoceptive exposure
* Relapse prevention (according to the protocol of Craske \& Barlow)

Wait-list control

Wait-list control group. Participants from this arm are randomized to the two active conditions after 10 weeks of waiting.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Virtual Reality Exposure Therapy for agoraphobic participants

This intervention is comprised of 10 sessions of cognitive behavior therapy for panic disorder and agoraphobia with components of

* Psycho-education, breathing training and cognitive restructuring
* Virtual reality Exposure to agoraphobic situations and interoceptive exposure
* Relapse prevention

Intervention Type BEHAVIORAL

Standard exposure in vivo for agoraphobic participants

This intervention is comprised of 10 sessions of cognitive behavior therapy for panic disorder and agoraphobia with components of

* Psycho-education, breathing training and cognitive restructuring
* Standard exposure in vivo to agoraphobic situations and interoceptive exposure
* Relapse prevention (according to the protocol of Craske \& Barlow)

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* A full diagnosis of panic disorder with agoraphobia according to the DSM-IV
* Between the ages of 18-65 years
* Sufficient fluency in Dutch to complete treatment and research protocol

Exclusion Criteria

* Presence of medical condition, assessed by self-report questionnaires at the intake (i.e., pregnancy, seizure disorder, pacemaker)
* Current use of Beta-blockers
* Current use of tranquilizers (Benzodiazepines)
* Unstable psychotropic medication
* Substance dependence
* Psychosis
* Depression with suicidal ideation
* Posttraumatic Stress Disorder
* Dementia or other severe cognitive impairment
* Bipolar Disorder
* Borderline Personality Disorder
* Anti-social Personality Disorder
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

VU University of Amsterdam

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Paul M.G.Emmelkamp

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Paul MG Emmelkamp, Professor

Role: PRINCIPAL_INVESTIGATOR

University of Amsterdam

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Amsterdam

Amsterdam, , Netherlands

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Netherlands

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KP-2008-518

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Virtual Reality for Youth Phobias
NCT05839431 COMPLETED NA